Skip to main content
. 2021 Mar 22;10(3):702. doi: 10.3390/cells10030702

Figure 3.

Figure 3

Mechanistic overview of fenamate neuropharmacology. This figure illustrates several diseases that can be targeted using fenamates and their three major pathways of interest. Tolfenamic acid (TA), mefenamic acid (MFA), meclofenamic acid (MCFA), flufenamic acid (FFA), NLR family pyrin domain-containing 3 (NLRP3), specificity protein 1 (SP1).